Ionic Transport Assays is Biotechnology in United States that focus on contract research services business. Founded in 2011. They cover business area such as operator, preclinical safety pharmacology assay, human heart cell, cellular pharmacology assay, adult human induce pluripotent stem cell-derive cardiomyocyte, new drug, clinical trial, company, drug effect, cardiac ionic current.
2011
( 15 years old in 2026 )
Contract Research Services
-
1100 Corporate Square Drive
Saint Louis, MO 63132
United States
Private
operatorpreclinical safety pharmacology assayhuman heart cellcellular pharmacology assayadult human induce pluripotent stem cell-derive cardiomyocytenew drugclinical trialcompanydrug effectcardiac ionic current
* We use standard office opening hours in near Ionic Transport Assays's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ionic Transport Assays is Biotechnology business from United States that founded in 2011 (15 years old in 2026), Ionic Transport Assays business is focusing on Contract Research Services.
Ionic Transport Assays headquarter office and corporate office address is located in 1100 Corporate Square Drive Saint Louis, MO 63132 United States.
Ionic Transport Assays was founded in United States.
In 2026, Ionic Transport Assays is currently focus on contract research services sector.
Above is snippet of Google Trends for "contract research services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ionic Transport Assays, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
